Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ikena Oncology Inc (NQ: IKNA )

1.380 -0.020 (-1.43%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 52,114
Open 1.410
Bid (Size) 1.310 (1)
Ask (Size) 1.390 (1)
Prev. Close 1.400
Today's Range 1.320 - 1.425
52wk Range 1.020 - 7.380
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
IKNA Stock Earnings: Ikena Oncology Beats EPS for Q1 2024
IKNA stock results show that Ikena Oncology beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update
From Ikena Oncology, Inc.
Via GlobeNewswire

Performance

YTD
-30.65%
-30.65%
1 Month
+6.15%
+6.15%
3 Month
-0.72%
-0.72%
6 Month
-13.75%
-13.75%
1 Year
-77.34%
-77.34%

More News

Read More
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum
From Ikena Oncology, Inc.
Via GlobeNewswire
The Analyst Landscape: 4 Takes On Ikena Oncology
Via Benzinga
Ikena Oncology: Q4 Earnings Insights
Via Benzinga
Ikena Oncology: Q3 Earnings Insights
Via Benzinga
Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
From Ikena Oncology, Inc.
Via GlobeNewswire
Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference
From Ikena Oncology, Inc.
Via GlobeNewswire
Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer
From Ikena Oncology, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Ikena Oncology Refocuses on Key Programs: Analysts Maintain Outperform Ratings Amid Strategic Organizational Changes
Via Benzinga
Ikena Oncology Outlines Key Priorities and Provides Corporate Updates
From Ikena Oncology, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Faraday Future Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Dow Falls Over 200 Points; Krispy Kreme Reports Downbeat Results
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Cancer Firm Ikena Oncology Stock Trading Lower Today?
Via Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Crude Oil Rises Over 1%; Tapestry Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results
From Ikena Oncology, Inc.
Via GlobeNewswire
Ikena Oncology to Present at Multiple November 2023 Investor Conferences
From Ikena Oncology, Inc.
Via GlobeNewswire
Optimism Surrounds Cancer Focused Ikena Oncology, Analyst Initiates With Outperform
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.